CLINICAL EFFECTIVENESS AND COST-ANALYSIS OF NEW ORAL ANTIDIABETICS IN A COHORT OF TYPE 2 DIABETIC PATIENTS FROM A CARDIOVASCULAR RISK PROGRAM IN COLOMBIA

被引：0
|
作者：
Echeverri, E. [1 ]
Ruiz, A. J. [2 ]
Rondon, M. [2 ]
Echeverri, S. [3 ]
Rosselli, D. [2 ]
机构：
[1] Pontificia Univ Javeriana, Cali, Colombia
[2] Pontificia Univ Javeriana, Bogota, Colombia
[3] Sci Po, Paris, France
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO191
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [41] Relation of pulse pressure and ambulatory arterial stiffness index with clinical characteristics and cardiovascular risk factors in type 2 diabetic patients
    Januszewicz, A.
    Ito, S.
    Izzo, J. L., Jr.
    Katayama, S.
    Mimran, A.
    Rabelink, A. J.
    Ritz, E.
    Ruilope, L. M.
    Rump, L. C.
    Viberti, G.
    Haller, H.
    DIABETOLOGIA, 2008, 51 : S498 - S498
  • [42] EFFECTIVENESS AND COST EFFECTIVENESS OF A MOBILE PHONE TEXT MESSAGING INTERVENTION FOR PREVENTION OF CARDIOVASCULAR RISK FACTORS AMONG PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL
    Islam, Sheikh Mohammed Shariful
    JOURNAL OF HYPERTENSION, 2018, 36 : E315 - E315
  • [43] Cost-Effectiveness Analysis of Efforts to Reduce Risk of Type 2 Diabetes and Cardiovascular Disease in Southwestern Pennsylvania, 2005-2007
    Smith, Kenneth J.
    Hsu, Heather E.
    Roberts, Mark S.
    Kramer, M. Kaye
    Orchard, Trevor J.
    Piatt, Gretchen A.
    Seidel, Miriam C.
    Zgibor, Janice C.
    Bryce, Cindy L.
    PREVENTING CHRONIC DISEASE, 2010, 7 (05):
  • [44] Clinical characteristics and cardiovascular disease risk in patients with diabetic painful neuropathy: an analysis from the 3B study
    Gao, Leili
    Ji, Linong
    Ji, Qiuhe
    Ran, Xingwu
    Su, Benli
    Weng, Jianping
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 5 - 6
  • [45] Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease
    Mafalda Ramos
    Volker Foos
    Anastasia Ustyugova
    Nikco Hau
    Pranav Gandhi
    Mark Lamotte
    Diabetes Therapy, 2019, 10 : 2153 - 2167
  • [46] Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease
    Ramos, Mafalda
    Foos, Volker
    Ustyugova, Anastasia
    Hau, Nikco
    Gandhi, Pranav
    Lamotte, Mark
    DIABETES THERAPY, 2019, 10 (06) : 2153 - 2167
  • [47] INSULIN USE AND EXCESS FRACTURE RISK AMONG TYPE 2 DIABETIC PATIENTS: A PROPENSITY-MATCHED COHORT ANALYSIS
    Losada-Grande, E.
    Soldevila, B.
    Hawley, S.
    Nogues, X.
    Diez-Perez, A.
    Martinez-Laguna, D.
    Puig-Domingo, M.
    Mauricio, D.
    Prieto-Alhambra, D.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S116 - S116
  • [48] COST-EFFECTIVENESS OF TRANSFERRING TYPE 2 DIABETIC PATIENTS FROM NEUTRAL PROTAMINE HAGEDORN (NPH) TO DETEMIR IN PORTUGAL SETTINGS
    Carvalho, D.
    Lindner, L.
    Kozarzewski, M.
    VALUE IN HEALTH, 2011, 14 (07) : A479 - A480
  • [49] Safety and effectiveness of insulin aspart in type 2 diabetic patients: Results from the ASEAN cohort of the A1chieve study
    Bebakar, Wan Mohamad Wan
    Lim-Abrahan, Mary Anne
    Jain, Anand B.
    Seah, Darren
    Soewondo, Pradana
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 : S17 - S23
  • [50] Central obesity markers, but not BMI, are associated with cardiovascular risk in type 2 diabetic patients: results from the ADVANCE study
    Czernichow, S.
    Huxley, R.
    Kengne, A. -P.
    de Galan, B.
    Pillai, A.
    Zoungas, S.
    Batty, D.
    Marre, M.
    Neal, B.
    Chalmers, J.
    DIABETOLOGIA, 2009, 52 : S62 - S62
12345